About
Ninti Pharma is a UK-based pharmaceutical and nutraceutical company operating as a Marketing Authorization Holder (MAH) with a strong international focus.
As part of the Panthera Group, it serves as a centralized platform for commercialization, regulatory management, and market expansion in regulated, high-growth markets.
The company specializes in structuring, authorizing, and scaling nutraceutical brands, partnering with qualified manufacturers to convert finished formulations into compliant, market-ready products for regional and global markets.
Our Core Services
“Ninti Pharma’s expertise drives excellence across pharmaceutical, nutraceutical, and regulated global markets.”
Our Market Focus
Our Market Focus reflects our strategic presence across key markets, driven by quality, innovation, and long-term partnerships.
01
Distribution Network
Efficient supply networks ensuring timely and reliable product delivery.
02
Global Expansion Strategy
Strategic growth into high-potential international healthcare markets.
03
Product Strategy
Innovative portfolio development aligned with market needs.
04
Quality, Compliance & Governance
Strict regulatory standards ensuring safety, integrity, and transparency.
05
Competitive Advantages
Strong partnerships, expertise, and differentiated market positioning.
06
Financial Projections
Sustainable revenue growth supported by strategic investments.
Our Vision & Mission
Mission
To design, authorize, and commercialize nutraceutical products through a structured, compliant, and growth-driven platform, starting in the MENA region and expanding globally.
Vision
To become a globally recognized Marketing Authorization Holder (MAH) and nutraceutical commercialization platform, trusted by manufacturers, distributors, and regulators for delivering high-quality, compliant food supplement products across international markets.